Obesity and metabolic syndrome: potential benefit from specific nutritional components
- PMID: 21764273
- DOI: 10.1016/j.numecd.2011.05.001
Obesity and metabolic syndrome: potential benefit from specific nutritional components
Abstract
The prevalence of metabolic syndrome (MetS) manifestations is rapidly increasing worldwide, and is becoming an important health problem. Actually, MetS includes a combination of clinical complications such as obesity (central adiposity), insulin resistance, glucose intolerance, dyslipidemia, non-alcoholic fatty liver disease and hypertension. All these alterations predispose individuals to type 2 diabetes and cardiovascular disease inducing earlier mortality rates among people. In general terms, it is difficult for patients to follow a standard long-term diet/exercise regime that would improve or alleviate MetS symptoms. Thus, the investigation of food components that may deal with the MetS features is an important field for ameliorate and facilitate MetS dietary-based therapies. Currently antioxidants are of great interest due to the described association between obesity, cardiovascular alterations and oxidative stress. On the other hand, high MUFA and PUFA diets are being also considered due to their potential benefits on hypertension, insulin resistance and triglyceride levels. Mineral composition of the diet is also relevant since high potassium intake may improve hypertension and high calcium consumption may promote lipid oxidation. Thus, although nutritional supplements are at the peak of dietetic therapies, the consumption of some specific foods (legumes, fatty fish, vegetables and fruits, etc) with bioactive components within an energy-restricted diet is a promising approach to manage MetS manifestations. Therefore, the present review focuses on some of the most important food components currently investigated to improve and make easier the nutritional MetS treatment.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA- cp rat model of the metabolic syndrome.Br J Nutr. 2011 Jun;105(11):1572-82. doi: 10.1017/S0007114510005453. Epub 2011 Jan 31. Br J Nutr. 2011. PMID: 21276281
-
n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.J Am Diet Assoc. 2005 Mar;105(3):428-40. doi: 10.1016/j.jada.2004.11.029. J Am Diet Assoc. 2005. PMID: 15746832 Review.
-
Metabolic syndrome: definition and therapeutic implications.Postgrad Med. 2012 Jan;124(1):21-30. doi: 10.3810/pgm.2012.01.2514. Postgrad Med. 2012. PMID: 22314111 Review.
-
The metabolic syndrome and its cardiovascular manifestations.Bol Asoc Med P R. 2005 Oct-Dec;97(4):271-80. Bol Asoc Med P R. 2005. PMID: 16599068 Review.
-
The metabolic syndrome: definitions, prevalence and management.J Nutrigenet Nutrigenomics. 2008;1(3):100-8. doi: 10.1159/000112457. Epub 2008 Feb 20. J Nutrigenet Nutrigenomics. 2008. PMID: 19776619 Review.
Cited by
-
Association between n-3 polyunsaturated fatty acids in erythrocytes and metabolic syndrome in Chinese men and women.Eur J Nutr. 2016 Apr;55(3):981-9. doi: 10.1007/s00394-015-0912-3. Epub 2015 May 3. Eur J Nutr. 2016. PMID: 25935580
-
Dietary Composition and Cardiovascular Risk: A Mediator or a Bystander?Nutrients. 2018 Dec 4;10(12):1912. doi: 10.3390/nu10121912. Nutrients. 2018. PMID: 30518065 Free PMC article. Review.
-
Dietary Strategies Implicated in the Prevention and Treatment of Metabolic Syndrome.Int J Mol Sci. 2016 Nov 10;17(11):1877. doi: 10.3390/ijms17111877. Int J Mol Sci. 2016. PMID: 27834920 Free PMC article. Review.
-
Role of LRP1 and ERK and cAMP Signaling Pathways in Lactoferrin-Induced Lipolysis in Mature Rat Adipocytes.PLoS One. 2015 Oct 27;10(10):e0141378. doi: 10.1371/journal.pone.0141378. eCollection 2015. PLoS One. 2015. PMID: 26506094 Free PMC article.
-
Co-Microencapsulation of Flavonoids from Yellow Onion Skins and Lactic Acid Bacteria Lead to Multifunctional Ingredient for Nutraceutical and Pharmaceutics Applications.Pharmaceutics. 2020 Nov 4;12(11):1053. doi: 10.3390/pharmaceutics12111053. Pharmaceutics. 2020. PMID: 33158041 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical